Cancer
Cancer
Comprehensive tools for oncology — from tumor biomarker quantification and apoptosis detection to drug screening and immunotherapy target validation.
Advancing the Fight Against Cancer
Cancer research demands reliable, validated tools across the entire spectrum of investigation — from understanding tumor biology and identifying therapeutic targets to screening drug candidates and monitoring treatment response. Enzo Life Sciences provides oncology researchers with a comprehensive portfolio of ELISA kits for tumor biomarkers, apoptosis and cell death detection assays, SCREEN-WELL libraries for anti-cancer compound screening, and validated antibodies against key oncology targets including PD-L1, HER2, Ki-67, and p53.
Cancer Research Areas
Key product categories for cancer research
Tumor Biomarker ELISAs
Sensitive ELISA kits for PSA, CEA, AFP, CA-125, HE4, and other clinically relevant tumor markers validated for serum, plasma, and cell culture analysis.
Apoptosis & Cell Death
Annexin V conjugates, caspase activity kits, TUNEL assays, and the proprietary CYTO-ID Autophagy Detection Kit for multiparameter tumor cell death analysis.
Anti-Cancer Drug Screening
SCREEN-WELL libraries with annotated anti-cancer compounds, kinase inhibitors, and epigenetic modulators pre-plated for HTS workflows.
SCREEN-WELL Anti-Cancer Compound Library
Our SCREEN-WELL Anti-Cancer Compound Library provides a curated collection of clinically relevant and mechanistically diverse anti-cancer agents. Each compound is annotated with target, mechanism of action, clinical status, and published IC50 data. The library supports drug repositioning studies, combination screening, and identification of synergistic drug pairs in tumor cell models.
Find Tools for Your Cancer Research
Explore our curated product selection for this research area or contact our scientific support team for personalized recommendations.